Magle Chemoswed Holding Management

Management criteria checks 2/4

Magle Chemoswed Holding's CEO is Justin Pierce, appointed in Jan 2015, has a tenure of 9.25 years. directly owns 1.6% of the company’s shares, worth SEK5.22M. The average tenure of the management team and the board of directors is 4.8 years and 6.8 years respectively.

Key information

Justin Pierce

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	9.3yrs
CEO ownership	1.6%
Management average tenure	4.8yrs
Board average tenure	6.8yrs

Recent management updates

Recent updates

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Apr 26

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Mar 29

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Oct 05

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Jan 22

CEO

Justin Pierce (50 yo)

9.3yrs

Tenure

Mr. Justin Pierce serves as Chief Executive Officer at Magle Chemoswed Holding AB (publ) since 2015.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Hans Lidgard	Founder & Chairman	11.3yrs	kr248.00k	74.01% SEK 241.4m
Justin Pierce	Chief Executive Officer	9.3yrs	no data	1.6% SEK 5.2m
Petra Sjolin	Chief Financial Officer	4.3yrs	no data	no data
Fredrik Andersson	Chief Operations Officer	5.3yrs	no data	no data
Megi Medzmariashvili	Legal Counsel	5.3yrs	no data	no data
Helena Thedius	Chief Marketing & Innovation Officer	1.6yrs	no data	no data
Simon Jegou	Chief Strategy Officer	2.3yrs	no data	no data

4.8yrs

Average Tenure

47yo

Average Age

Experienced Management: MAGLE's management team is considered experienced (4.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Hans Lidgard	Founder & Chairman	11.3yrs	kr248.00k	74.01% SEK 241.4m
Sven-Christer Nilsson	Director	8.3yrs	kr138.00k	0.50% SEK 1.6m
Mats Pettersson	Director	8.3yrs	kr138.00k	2% SEK 6.5m
Joel Eklund	Director	3.5yrs	kr131.00k	10.58% SEK 34.5m
Claudia Lindwall	Staff Representative Director	3.3yrs	no data	no data
Malin Malmsjö	Director	8.3yrs	kr131.00k	no data
Ingela Fritzon	Staff Representative Director	5.3yrs	no data	no data
Martin Lidgard	Director	2.3yrs	kr131.00k	0.26% SEK 854.5k

6.8yrs

Average Tenure

59.5yo

Average Age

Experienced Board: MAGLE's board of directors are considered experienced (6.8 years average tenure).

Magle Chemoswed Holding Management

Management criteria checks 2/4

Key information

Recent management updates

No independent directors

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

No independent directors

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Recent updates

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

First quarter 2024 earnings released: EPS: kr0.27 (vs kr0.27 in 1Q 2023)

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Magle Chemoswed Holding AB (publ) (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (publ) (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.

Full year 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Financial data availability

Magle Chemoswed Holding AB (publ) to Report Q4, 2024 Results on Feb 26, 2025

No independent directors

New minor risk - Share price stability

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr0.87 (vs kr0.39 in FY 2021)

Magle Chemoswed Holding AB 's Proprietary Product Axxo® Woundgel Receives Regulatory Approval in Kuwait

Magle Group's Vascular Embolic Product Embocept® S Receives Regulatory Approval in Argentina

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

Magle Group Announces First Patients Enrolled in a Post-Market Study of Medical Device SmartPAN®

Magle Chemoswed Holding AB (publ) Announces Post Market Clinical Study for SmartPAN®

Magle Chemoswed Holding AB (publ) to Report Q4, 2022 Results on Feb 16, 2023

Investor sentiment deteriorated over the past week

No independent directors

Full year 2021 earnings released: EPS: kr0.39 (vs kr0.24 in FY 2020)

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2021 Results on Feb 25, 2022

Full year 2020 earnings released: EPS kr0.24

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: kr44.60

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 20 million.

New 90-day high: kr35.00

New 90-day high: kr34.60

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr33.50

New 90-day high: kr30.90

Magle Chemoswed Holding AB (Publ) Announces the Appointment of Joel Eklund as New Member of the Board

Magle Chemoswed Holding AB (publ) has completed an IPO in the amount of SEK 50 million.

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age